Trials / Conditions / Haemophilia B With Inhibitors

Haemophilia B With Inhibitors

26 registered clinical trials studyying Haemophilia B With Inhibitors.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibit NCT04083781	Novo Nordisk A/S	Phase 3
Completed	A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explor NCT03741881	Novo Nordisk A/S	—
Completed	A Trial Evaluating the Efficacy and Safety of Prophylactic Administration of Concizumab in Haemophilia A and B NCT03196284	Novo Nordisk A/S	Phase 2
Completed	Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in NCT02541942	Novo Nordisk A/S	Phase 2
Completed	To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives NCT02241694	Novo Nordisk A/S	—
Withdrawn	Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects NCT02084810	Novo Nordisk A/S	Phase 1
Completed	Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia NCT01988532	Novo Nordisk A/S	—
Completed	A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B NCT01949792	Novo Nordisk A/S	Phase 1
Completed	Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries NCT01503567	Novo Nordisk A/S	—
Completed	Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors NCT01392547	Novo Nordisk A/S	Phase 3
Completed	Survey Evaluating the Psychosocial Effects of Living With Haemophilia NCT01322620	Novo Nordisk A/S	—
Completed	A Long-term Assessment of Physical Activity, Range of Motion, and Functional Status Following Elective Orthope NCT01830712	Novo Nordisk A/S	—
Completed	Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibit NCT00951405	Novo Nordisk A/S	Phase 2
Completed	PROPACT: Retrospective Prophylaxis Patient Case Collection NCT00882778	Novo Nordisk A/S	—
Completed	Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors NCT00710619	Novo Nordisk A/S	—
Completed	Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and NCT00703911	Novo Nordisk A/S	—
Completed	Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects NCT01561417	Novo Nordisk A/S	Phase 1
Completed	Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Pa NCT01561924	Novo Nordisk A/S	Phase 1
Completed	Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia NCT00108758	Novo Nordisk A/S	Phase 2
Completed	High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia NCT00571584	Novo Nordisk A/S	Phase 4
Completed	Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers NCT01563471	Novo Nordisk A/S	Phase 1
Completed	Trial of NovoSeven® in Haemophilia - Joint Bleeds NCT00108797	Novo Nordisk A/S	Phase 4
Completed	Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal NCT01579955	Novo Nordisk A/S	—
Completed	Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A an NCT01586936	Novo Nordisk A/S	—
Completed	Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoi NCT01579968	Novo Nordisk A/S	—
Completed	Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During a NCT01561391	Novo Nordisk A/S	Phase 4